International Federation of Pharmaceutial Manufacturers and Associations
Recent meetings
| Date | Commissioner / Cabinet | Topic | File |
|---|---|---|---|
| 04 Nov 2025 | Laszlo Kristoffy Cabinet member | Competitiveness of the pharma industry | SRC |
| 04 Nov 2025 | Olivér Várhelyi Commissioner | Competitiveness of the pharma industry | SRC |
| 04 Nov 2025 | Olivér Várhelyi Commissioner | Competitiveness of the pharma industry | — |
| 09 Jun 2020 | Kurt Vandenberghe Cabinet member | COVID 19 | — |
| 09 Jun 2020 | Kurt Vandenberghe Cabinet member | COVID 19 | SRC |
| 09 Jun 2020 | Kurt Vandenberghe Cabinet member | COVID-19 | SRC |
| 09 Jun 2020 | Kurt Vandenberghe Cabinet member | COVID-19 | — |
| 04 Jun 2020 | Kurt Vandenberghe Cabinet member | COVID 19 | — |
| 04 Jun 2020 | Kurt Vandenberghe Cabinet member | COVID 19 | SRC |
| 27 May 2020 | Kurt Vandenberghe Cabinet member | COVID 19 | SRC |
| 27 May 2020 | Kurt Vandenberghe Cabinet member | COVID 19 | — |
| 05 May 2020 | Kurt Vandenberghe Cabinet member | COVID 19 | — |
| 05 May 2020 | Kurt Vandenberghe Cabinet member | COVID 19 | SRC |
Mission & Goals
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents over 90 innovative pharmaceutical companies and associations across the globe. Based in Geneva, IFPMA has official relations with the United Nations. IFPMA promotes sustainable solutions that encourage pharmaceutical innovation and improve people’s health around the world. The industry’s two million employees discover, develop, and deliver medicines and vaccines that advance global health. IFPMA works closely with all public health stakeholders in the UN system, including the World Health Organization, World Trade Organization, and World Intellectual Property Organization; all organizations that the EU engages with on behalf of the EU member states. Collaborating with global health stakeholders to promote sustainable policies and initiatives that encourage pharmaceutical innovation and support access to vaccines and medicines for people globally
EU Legislative Interests
HERA regulation One Health approach to tackle AMR COVID-19 outbreak measures and pandemic Accord IP Policy
Communication Activities
IPSOS Survey Drafting blog posts to share opinions Organising events including IFPMA members and external stakeholders Disseminating our key messages through media and social media Vaccine Access & Uptake Policy narrative LCI Working Group policy position papers
Interests Represented
Promotes their own interests or the collective interests of their members
Organisation Members
www.efpia.eu www.phrma.org
Connected Legislation